Table 2.
(1) | The detection of unimportant incidental disease |
---|---|
(2) | The detection of important incidental disease |
(3) | The detection of pseudodisease |
(4) | Failure to detect important screened disease |
(5) | The consequences of investigation and treatment of detected disease |
(6) | Interval cancers |
(7) | Opportunity costs |